The global hypertension drugs market is anticipated to grow at a considerable CAGR of 4% during the forecast period (2022-2028). The major players operating in the global hypertension drug market adopts various strategies including acquisitions, partnerships, collaborations, and new product launch to stay competitive in the market. For instance, in December 2021, Alembic Pharmaceuticals has received approval from the US Food and Drug Administration (USFDA) to market Selexipag tablets, which are used to treat high blood pressure. The USFDA has tentatively approved the company’s abbreviated new drug application (ANDA) for Selexipag tablets in the strengths including 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1,400 mcg, and 1,600 mcg. Alembic’s product is a generic version of Uptravi, a reference listed drug product (RLD). Selexipag Tablets are used to treat pulmonary arterial hypertension (PAH).
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/hypertension-drug-market
In December 2021, Dr Reddy’s launched Dr Reddy’s Laboratories announced that Valsartan pills, which are used to treat high blood pressure and heart failure, are now available in the US. The Valsartan pill has been authorised by the USGFDA as the generic therapeutic equivalent of Diovan. Dr. Reddy’s Valsartan Tablets come in doses of 40 mg in a 30-count bottle and 80 mg, 160 mg, and 320 mg in a 60-count bottle. In April 2021, United Therapeutic’s Tyvaso (treprostinil) Inhalation Solution has been approved by the FDA for the treatment of individuals with pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability. Tyvaso was first licenced by the FDA in July 2009 for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) with the goal of improving exercise ability.
Market Coverage
- The market number available for – 2022-2028
- Base year- 2022
- Forecast period- 2022-2028
Segment Covered-
- By Drug Type
- By Distribution Channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape – AstraZeneca Plc., Bayers AG, Daiichi Sankyo Company Ltd., Novartis International AG, Pfizer Inc., and many more.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Hypertension Drugs Market Report Segment
By Drug Type
- Diuretics
- ACE Inhibitors,
- Calcium Channel Blockers
- Vasodilators
- Beta-adrenergic Blockers
- Others
By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- E-Commerce
A full report of Hypertension Drug Market is available at: https://www.omrglobal.com/industry-reports/hypertension-drug-market
Hypertension Drug Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Boehringer Ingelheim International GmbH
- Boryung Co. Ltd.
- Cipla Inc.
- Hoffman La. Roche Ltd.
- GlaxoSmithKline
- Gilead Sciences, Inc.
- JW Pharmaceutical
- Johnson & Johnson Services
- Merck KGaA
- Sanofi
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
